Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 5.8d

Adjusted Graft Survival, Living Donor Kidney Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2006 - 2007) (Tx 2006 - 2007) (Tx 2002 - 2007) (Tx 1997 - 2007)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 12,462 98.1% 0.1% 12,462 96.4% 0.2% 38,350 81.4% 0.3% 62,864 58.9% 0.4%
Primary Diagnosis Glomerular Diseases 3,643 97.8% 0.2% 3,643 96.3% 0.3% 11,412 82.7% 0.5% 19,236 63.7% 0.7%
Diabetes 2,639 98.5% 0.2% 2,639 96.6% 0.4% 8,136 77.3% 0.7% 13,161 47.8% 0.9%
Hypertensive Nephrosclerosis 2,035 98.0% 0.3% 2,035 96.0% 0.4% 5,463 79.1% 0.9% 8,125 53.0% 1.3%
Polycystic Kidneys 1,320 98.2% 0.4% 1,320 97.3% 0.4% 3,910 89.4% 0.7% 5,921 73.3% 1.3%
Tubular and Interstitial Diseases 711 97.8% 0.5% 711 96.2% 0.7% 2,456 81.3% 1.1% 4,325 60.7% 1.4%
Renovascular & Other Vascular Diseases 250 97.3% 1.0% 250 95.3% 1.3% 1,130 79.5% 1.5% 2,097 49.3% 2.4%
Congenital, Rare Familial, & Metabolic Disorders 460 97.8% 0.7% 460 94.8% 1.2% 1,594 82.6% 1.4% 2,649 65.7% 1.8%
Neoplasms 49 100.0% 0.0% 49 97.9% 2.0% 161 79.1% 4.3% 262 61.8% 5.8%
Other 1,250 98.1% 0.4% 1,250 96.2% 0.6% 3,614 81.0% 0.9% 6,051 60.3% 1.3%
Unknown 105 99.1% 0.9% 105 98.1% 1.3% 474 79.3% 2.3% 1,037 55.4% 3.0%


Source: OPTN/SRTR Data as of May 4, 2009.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on kidney and kidney-pancreas transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.



PDF FormatRequires Adobe Acrobat Reader